A doctor writes a prescription. The patient drives to the pharmacy, expecting a bag and a receipt. Instead comes the phrase that derails an afternoon: “Your insurance requires prior authorization.” The medication sits in limbo — approved by a physician, denied at the counter — while paperwork moves between a clinic and an insurance company on a timeline nobody explains up front.
Prior authorization is one of the more common friction points in American health care, and one of the least understood until it happens to someone directly. It applies most often to newer brand-name drugs, certain high-cost medications, imaging like MRIs, and some specialist procedures. The insurer isn’t refusing to pay; it’s asking the prescriber to justify the choice first, usually by filling out a form explaining why a cheaper or more established option won’t work. In theory this keeps costs down and steers patients toward equally effective, lower-cost alternatives. In practice it can mean days or weeks of delay for a person who needed the medication that same afternoon.
Why the Delay Happens
The request doesn’t go directly from pharmacy to insurer. It usually routes through the prescribing office, which has to pull the chart, complete the insurer’s specific form, and submit supporting documentation — lab results, prior treatment history, notes on why alternatives failed or aren’t appropriate. Larger practices often have staff dedicated to this task; smaller ones may handle it between patient visits, which is where delays tend to compound. Insurers, for their part, are not required to respond instantly. Many operate on a standard review window measured in business days, with a separate, faster track reserved for cases marked urgent.
That urgent track matters more than most patients realize. A request flagged as routine can sit in a queue behind dozens of others. A request flagged as urgent — because a delay would risk the patient’s health — is often required to be reviewed on a much shorter clock. The catch: someone has to actually check that box, and it doesn’t happen automatically just because a patient feels the situation is urgent.
What Often Gets Missed
A few details tend to surprise people the first time they run into this process.
The pharmacy usually finds out before the patient does. Many pharmacies can see that a prior authorization is required at the moment they try to process the claim, sometimes before the patient has even left the counter. Asking directly — “does this need prior auth, and has the office been notified?” — can save a wasted trip home and back.
Approval isn’t guaranteed, even with a valid prescription. Insurers can deny the request if they determine a lower-cost alternative should be tried first, a practice sometimes called step therapy. A denial isn’t necessarily final; it can usually be appealed, and prescribers can often request a peer-to-peer review, where the prescribing physician talks directly with a medical reviewer at the insurance company.
The clock often doesn’t start until the paperwork is complete. If a form is missing a signature or a required lab value, the review period may not begin until the resubmission arrives. A single incomplete fax can add several days without anyone doing anything obviously wrong.
Some medications need this every time they’re renewed, not just once. A prior authorization approval is frequently tied to a specific time window, often six months to a year. When it expires, the process can restart from the beginning, sometimes catching patients off guard mid-refill.
What Tends to Help
There’s no way to guarantee a prior authorization moves quickly, but a few habits seem to reduce the odds of an extended gap.
Ask about it at the point of prescribing, not after the pharmacy rejection. If a physician’s office knows a medication commonly requires prior authorization, the paperwork can sometimes be started the same day, before the patient has even left the building.
Request a bridge supply. Many pharmacies can dispense a short-term supply — often a few days’ worth — while authorization is pending, particularly for medications where stopping abruptly carries risk. This isn’t automatic and isn’t available for every drug, but it’s worth asking about specifically rather than assuming it doesn’t exist.
Follow up rather than wait. Prior authorization requests can stall simply because a fax didn’t go through or a form landed in the wrong queue. A phone call to the prescriber’s office a day or two after submission, confirming the insurer actually received it, sometimes catches an error before it becomes a week-long delay.
Keep a paper trail. Reference numbers, the names of representatives spoken with, and dates of each call make a real difference if an appeal becomes necessary. Insurance disputes that drag on tend to be won or lost on documentation.
Understand the appeal path before it’s needed. Every insurer is required to provide a way to appeal a denial, and most plans outline a timeline for both standard and expedited appeals in the plan’s benefits documents. Knowing where that document lives — rather than searching for it during a crisis — can shave real time off a dispute.
The Larger Pattern
None of this is unique to any one insurer or any one pharmacy chain; it’s closer to a structural feature of how many health plans manage cost, applied unevenly depending on the drug, the plan, and sometimes the specific pharmacy benefit manager involved. For patients managing a chronic condition, the frustration often isn’t the concept of review itself — most understand why costly treatments get a second look — it’s the lack of visibility into where a request sits at any given moment, and how easily it can slip through a scheduling gap between two organizations that don’t share a system.
The most reliable defense, for now, tends to be treating prior authorization as a known step rather than a surprise: asking about it before leaving the doctor’s office, confirming timelines instead of assuming them, and following up rather than waiting quietly for a callback that may or may not come.
